Ertapenem Sodium

Communicable Diseases, moderate, severe Complicated Skin and Soft Tissue Infection, moderate, severe Diabetic Foot Infection + 5 more

Treatment

0 Active Studies for Ertapenem Sodium

Treatment for

Communicable Diseases

What is Ertapenem Sodium

ErtapenemThe Generic name of this drug

Treatment SummaryErtapenem is an antibiotic drug used to treat infections caused by bacteria. It is sold under the brand name Invanz and is similar to another antibiotic called meropenem. Ertapenem contains a special ingredient, a 1-beta-methyl group, which helps make it effective against certain types of bacteria.

Invanzis the brand name

Ertapenem Sodium Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Invanz

Ertapenem

2001

Effectiveness

How Ertapenem Sodium Affects PatientsErtapenem has been proven to be effective against a variety of bacteria, both those that need oxygen to survive (aerobic) and those that don't (anaerobic), as well as both types of bacteria that cause infections (gram-positive and gram-negative).

How Ertapenem Sodium works in the bodyErtapenem works to kill bacteria by interrupting the process of making their cell wall. It does this by binding to molecules, called penicillin binding proteins, which are involved in cell wall formation. Ertapenem has a strong preference for two particular molecules, PBPs 2 and 3, and is resistant to most types of beta-lactamases. However, it can be broken down by metallo-beta-lactamases.

When to interrupt dosage

The suggested amount of Ertapenem Sodium is contingent upon the diagnosed issue, including Abortion, Septic, moderate, severe Complicated Intra-Abdominal Infections and moderate, severe Diabetic Foot Infection. The dosage varies, as per the delivery approach featured in the table beneath.

Condition

Dosage

Administration

moderate, severe Complicated Skin and Soft Tissue Infection

, 1000.0 mg, 100.0 mg/mL

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, Injection - Intramuscular; Intravenous

moderate, severe Diabetic Foot Infection

, 1000.0 mg, 100.0 mg/mL

Communicable Diseases

, 1000.0 mg, 100.0 mg/mL

moderate, severe Community Acquired Pneumonia (CAP)

, 1000.0 mg, 100.0 mg/mL

Abortion, Septic

, 1000.0 mg, 100.0 mg/mL

Intraabdominal Infections

, 1000.0 mg, 100.0 mg/mL

Urinary tract infection

, 1000.0 mg, 100.0 mg/mL

Endometritis

, 1000.0 mg, 100.0 mg/mL

Warnings

Ertapenem Sodium Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Ertapenem may interact with Pulse Frequency

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Ertapenem Sodium.

Common Ertapenem Sodium Drug Interactions

Drug Name

Risk Level

Description

Vibrio cholerae CVD 103-HgR strain live antigen

Major

The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ertapenem.

Abacavir

Minor

Ertapenem may decrease the excretion rate of Abacavir which could result in a higher serum level.

Acetaminophen

Minor

Ertapenem may decrease the excretion rate of Acetaminophen which could result in a higher serum level.

Aclidinium

Minor

Ertapenem may decrease the excretion rate of Aclidinium which could result in a higher serum level.

Acrivastine

Minor

Ertapenem may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Ertapenem Sodium Toxicity & Overdose RiskThe lowest toxic dose of the drug when taken orally in mice has been found to be greater than 500mg/kg.

Ertapenem Sodium Novel Uses: Which Conditions Have a Clinical Trial Featuring Ertapenem Sodium?

No active clinical trials are currently being conducted to evaluate the potential of Ertapenem Sodium to provide relief from Abortion, Septic, moderate-to-severe Community Acquired Pneumonia (CAP) and moderate-to-severe Diabetic Foot Infection.

Condition

Clinical Trials

Trial Phases

moderate, severe Complicated Skin and Soft Tissue Infection

0 Actively Recruiting

moderate, severe Diabetic Foot Infection

0 Actively Recruiting

Endometritis

0 Actively Recruiting

moderate, severe Community Acquired Pneumonia (CAP)

0 Actively Recruiting

Urinary tract infection

0 Actively Recruiting

Abortion, Septic

0 Actively Recruiting

Intraabdominal Infections

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Patient Q&A Section about ertapenem sodium

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is another name for Ertapenem?

"Ertapenem is a carbapenem antibiotic drug that is marketed under the trade name Invanz by Merck & Co. It is used to treat a variety of infections, including those of the skin, lungs, abdomen, and urinary tract."

Answered by AI

What bacteria does Ertapenem treat?

"Ertapenem is a broad-spectrum antibiotic that is effective against many different types of bacteria, including Enterobacteriaceae. It can be administered once per day, making it a convenient option for treatment."

Answered by AI

What are the side effects of Ertapenem?

"You may experience some side effects after getting a vaccine, like swelling, redness, or pain at the injection site. You could also have stomach issues, like upset stomach, headache, nausea, vomiting, or diarrhea. If any of these effects don't go away or they get worse, let your doctor or pharmacist know."

Answered by AI

What is ertapenem sodium used for?

"Ertapenem is used to treat pneumonia, urinary tract infections, skin infections, diabetic foot infections, gynecological infections, pelvic infections, and abdominal infections caused by bacteria. Ertapenem is also used to prevent infections following colorectal surgery."

Answered by AI